ProShare Advisors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-11,849
| Closed | -$90K | – | 2185 |
|
|
2022
Q1 | $90K | Sell |
11,849
-2,798
| -19% | -$21.3K | ﹤0.01% | 2055 |
|
|
2021
Q4 | $149K | Buy |
14,647
+577
| +4% | +$5.87K | ﹤0.01% | 2129 |
|
|
2021
Q3 | $189K | Sell |
14,070
-3,660
| -21% | -$49.2K | ﹤0.01% | 1806 |
|
|
2021
Q2 | $389K | Buy |
17,730
+2,820
| +19% | +$61.9K | ﹤0.01% | 1714 |
|
|
2021
Q1 | $359K | Buy |
14,910
+1,485
| +11% | +$35.8K | ﹤0.01% | 1686 |
|
|
2020
Q4 | $242K | Buy |
13,425
+3,116
| +30% | +$56.2K | ﹤0.01% | 1751 |
|
|
2020
Q3 | $119K | Sell |
10,309
-359
| -3% | -$4.14K | ﹤0.01% | 1510 |
|
|
2020
Q2 | $259K | Buy |
+10,668
| New | +$259K | ﹤0.01% | 1311 |
|
|
2020
Q1 | – | Sell |
-12,714
| Closed | -$336K | – | 1647 |
|
|
2019
Q4 | $336K | Sell |
12,714
-1,297
| -9% | -$34.3K | ﹤0.01% | 1274 |
|
|
2019
Q3 | $319K | Buy |
14,011
+620
| +5% | +$14.1K | ﹤0.01% | 1193 |
|
|
2019
Q2 | $411K | Sell |
13,391
-1,840
| -12% | -$56.5K | ﹤0.01% | 1096 |
|
|
2019
Q1 | $253K | Buy |
15,231
+228
| +2% | +$3.79K | ﹤0.01% | 1343 |
|
|
2018
Q4 | $287K | Sell |
15,003
-1,168
| -7% | -$22.3K | ﹤0.01% | 1184 |
|
|
2018
Q3 | $846K | Sell |
16,171
-260
| -2% | -$13.6K | 0.01% | 896 |
|
|
2018
Q2 | $714K | Buy |
16,431
+1,554
| +10% | +$67.5K | ﹤0.01% | 965 |
|
|
2018
Q1 | $551K | Sell |
14,877
-1,561
| -9% | -$57.8K | ﹤0.01% | 1060 |
|
|
2017
Q4 | $326K | Buy |
+16,438
| New | +$326K | ﹤0.01% | 1341 |
|